Paper36745974
A unified classification approach rating clinical utility of protein biomarkers across neurologic diseases.
Bernhardt AM and 27 others. EBioMedicine, 2023. Cited by 25 papers, by iCite.
Cite this record
ConductScience Library. A unified classification approach rating clinical utility of protein biomarkers across neurologic diseases. Papers, record 36745974. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36745974
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- A unified classification approach rating clinical utility of protein biomarkers across neurologic diseases.
- PubMed
Topics6
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Nervous System Diseases | Major topic |
| Humans | |
| Biomarkers | |
| Proteomics | |
| Mass Spectrometry | |
| Neuroimaging |
Source PubMed
Cited by17
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 25 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42585605 | Blood-Based Biomarkers for Alzheimer Disease in Primary Care: The Gap Between Biology and Clinical Utility. | Neurology | 2026 | https://conductscience.org/library/papers/42585605 | PubMed |
| 42382525 | From clinical phenotypes to molecular stratification: early differential diagnosis of four-repeat tauopathies. | Front Aging Neurosci | 2026 | https://conductscience.org/library/papers/42382525 | PubMed |
| 41928086 | Plasma proteomics identifies proteins and pathways associated with incident migraine in 50,668 adults. | J Headache Pain | 2026 | https://conductscience.org/library/papers/41928086 | PubMed |
| 41794848 | Artificial intelligence-based biomarkers for the diagnosis and treatment of neurological conditions: a narrative review. | Mol Brain | 2026 | https://conductscience.org/library/papers/41794848 | PubMed |
| 41594172 | Predictive Biomarkers for Asymptomatic Adults: Opportunities, Risks, and Guidance for General Practice. | Diagnostics (Basel) | 2026 | https://conductscience.org/library/papers/41594172 | PubMed |
| 41383374 | Mass spectrometry-based proteomics for biomarker discovery in the Drosophila model of Parkinson's disease. | Neuroprotection | 2024 | https://conductscience.org/library/papers/41383374 | PubMed |
| 41210849 | Preeclampsia prediction and diagnosis: a comprehensive historical review from clinical insights to omics perspectives. | Front Med (Lausanne) | 2025 | https://conductscience.org/library/papers/41210849 | PubMed |
| 40447964 | Genetics and Epigenetics of Alzheimer's Disease: Understanding Pathogenesis and Exploring Therapeutic Potential. | J Mol Neurosci | 2025 | https://conductscience.org/library/papers/40447964 | PubMed |
| 40292039 | Real-world clinical utility of a multi-protein, blood-based biomarker assay for disease activity assessments in multiple sclerosis. | Mult Scler J Exp Transl Clin | 2025 | https://conductscience.org/library/papers/40292039 | PubMed |
| 39488513 | Biomarkers for cognitive impairment in alpha-synucleinopathies: an overview of systematic reviews and meta-analyses. | NPJ Parkinsons Dis | 2024 | https://conductscience.org/library/papers/39488513 | PubMed |
| 39263969 | Combining cerebrospinal fluid and PI-2620 tau-PET for biomarker-based stratification of Alzheimer's disease and 4R-tauopathies. | Alzheimers Dement | 2024 | https://conductscience.org/library/papers/39263969 | PubMed |
| 39254698 | GFAP and NfL as fluid biomarkers for clinical disease severity and disease progression in multiple system atrophy (MSA). | J Neurol | 2024 | https://conductscience.org/library/papers/39254698 | PubMed |
| 38561692 | Increased CX3CL1 in cerebrospinal fluid and ictal serum t-tau elevations in migraine: results from a cross-sectional exploratory case-control study. | J Headache Pain | 2024 | https://conductscience.org/library/papers/38561692 | PubMed |
| 38087173 | Common Data Elements for Disorders of Consciousness: Recommendations from the Working Group on Biospecimens and Biomarkers. | Neurocrit Care | 2024 | https://conductscience.org/library/papers/38087173 | PubMed |
| 38015820 | Multicenter Collaborative Study to Optimize Mass Spectrometry Workflows of Clinical Specimens. | J Proteome Res | 2024 | https://conductscience.org/library/papers/38015820 | PubMed |
| 37569895 | Fluid Biomarkers of Neuro-Glial Injury in Human Status Epilepticus: A Systematic Review. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/37569895 | PubMed |
| 37308838 | Neuroinflammation and Brain Disease. | BMC Neurol | 2023 | https://conductscience.org/library/papers/37308838 | PubMed |
Genes36
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36745974
GET https://conductscience.org/api/papers/v1/36745974/authors?page=2